Gregory S Adey, MD in Portland, ME - Medicare Urology

Gregory S Adey, MD is a medicare enrolled "Urology" physician in Portland, Maine. He graduated from medical school in 2000 and has 24 years of diverse experience with area of expertise as Urology. He is a member of the group practice Fore River Urology Llc and his current practice location is 195 Fore River Parkway, Suite 310, Portland, Maine. You can reach out to his office (for appointments etc.) via phone at (207) 523-5901.

Gregory S Adey is licensed to practice in Maine (license number 016729) and he also participates in the medicare program. He may accept medicare assignments (which means he may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance) and his NPI Number is 1578506143.

Contact Information

	Gregory S Adey, MD
	195 Fore River Parkway, Suite 310, Portland, ME 04101-2715
	(207) 523-5901
	(207) 523-5902

Physician's Profile

Full Name	Gregory S Adey
Gender	Male
Speciality	Urology
Experience	24 Years
Location	195 Fore River Parkway, Portland, Maine
Accepts Medicare Assignments	May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance.

Medical Education and Training:

Gregory S Adey graduated from medical school in 2000

NPI Data:

NPI Number: 1578506143
Provider Enumeration Date: 06/13/2006
Last Update Date: 04/03/2008

Medicare PECOS Information:

PECOS PAC ID: 5092751529
Enrollment ID: I20050706000371

Medical Identifiers

Medical identifiers for Gregory S Adey such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1578506143	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	016729 (Maine)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Northern Light Mercy Hospital	Portland, ME	Hospital
Maine Medical Center	Portland, ME	Hospital
York Hospital	York, ME	Hospital
Mid Coast Hospital	Brunswick, ME	Hospital
Southern Maine Health Care	Biddeford, ME	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Fore River Urology Llc	5799911566	7

News Archive

VIVUS submits a NDA to the FDA for obesity drug Qnexa

VIVUS, Inc., a biopharmaceutical company developing innovative, next-generation medical therapies to address unmet needs in obesity, diabetes and sexual health, announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of Qnexa, its investigational drug for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity.

Smokers with higher math ability more likely to intend to quit

For smokers who are better at math, the decision to quit just adds up, a new study suggests.Researchers found that smokers who scored higher on a test of math ability were more likely than others to say they intended to quit smoking.

MU, MIT researchers evaluate accuracy of new technology to monitor blood glucose levels

For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related complications such as heart attacks, blindness and coma.

Sandia receives four R&D Magazine's 2011 awards

Sandia National Laboratories researchers - competing in an international pool of universities, corporations and government labs - captured three prestigious R&D 100 Awards in this year's contest, and were cowinners of a fourth.

NW Bio receives MHRA approval to initiate DCVax-L Phase III GBM brain cancer trial in the U.K.

Northwest Biotherapeutics announced today that it has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) of the United Kingdom, for the Company's 300-patient Phase III clinical trial of DCVax-L immune therapy for Glioblastoma multiforme brain cancer (GBM) to proceed in the U.K.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Gregory S Adey allows following entities to bill medicare on his behalf.

Entity Name	Central Maine Medical Center
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1689653487 PECOS PAC ID: 2567379563 Enrollment ID: O20040324000441

News Archive

VIVUS submits a NDA to the FDA for obesity drug Qnexa

Smokers with higher math ability more likely to intend to quit

MU, MIT researchers evaluate accuracy of new technology to monitor blood glucose levels

For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related complications such as heart attacks, blindness and coma.

Sandia receives four R&D Magazine's 2011 awards

NW Bio receives MHRA approval to initiate DCVax-L Phase III GBM brain cancer trial in the U.K.

Entity Name	Fore River Urology Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1003248436 PECOS PAC ID: 5799911566 Enrollment ID: O20131127000198

VIVUS submits a NDA to the FDA for obesity drug Qnexa

Smokers with higher math ability more likely to intend to quit

MU, MIT researchers evaluate accuracy of new technology to monitor blood glucose levels

For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related complications such as heart attacks, blindness and coma.

Sandia receives four R&D Magazine's 2011 awards

NW Bio receives MHRA approval to initiate DCVax-L Phase III GBM brain cancer trial in the U.K.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Gregory S Adey is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Gregory S Adey, MD 144 State St, Portland, ME 04101-3776 Ph: (207) 879-3000	Gregory S Adey, MD 195 Fore River Parkway, Suite 310, Portland, ME 04101-2715 Ph: (207) 523-5901

News Archive

VIVUS submits a NDA to the FDA for obesity drug Qnexa

Smokers with higher math ability more likely to intend to quit

MU, MIT researchers evaluate accuracy of new technology to monitor blood glucose levels

For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related complications such as heart attacks, blindness and coma.

Sandia receives four R&D Magazine's 2011 awards

NW Bio receives MHRA approval to initiate DCVax-L Phase III GBM brain cancer trial in the U.K.

Urology Doctors in Portland, ME

Marc A Hodroff, M.D. Urology Medicare: May Accept Medicare Assignments Practice Location: 195 Fore River Parkway, Suite 310, Portland, ME 04102 Phone: 207-523-5901 Fax: 207-523-5902
Benjamin Jacob Scoll, M.D. Urology Medicare: May Accept Medicare Assignments Practice Location: 195 Fore River Pkwy, Suite 310, Portland, ME 04102 Phone: 207-523-5901 Fax: 207-523-5902
David Watson Sobel, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 100 Brickhill Ave, Portland, ME 04106 Phone: 207-773-1728

Gregory S Adey, MD - Medicare Urology in Portland, ME

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

VIVUS submits a NDA to the FDA for obesity drug Qnexa

Smokers with higher math ability more likely to intend to quit

MU, MIT researchers evaluate accuracy of new technology to monitor blood glucose levels

Sandia receives four R&D Magazine's 2011 awards

NW Bio receives MHRA approval to initiate DCVax-L Phase III GBM brain cancer trial in the U.K.

Medicare Reassignments

VIVUS submits a NDA to the FDA for obesity drug Qnexa

Smokers with higher math ability more likely to intend to quit

MU, MIT researchers evaluate accuracy of new technology to monitor blood glucose levels

Sandia receives four R&D Magazine's 2011 awards

NW Bio receives MHRA approval to initiate DCVax-L Phase III GBM brain cancer trial in the U.K.

VIVUS submits a NDA to the FDA for obesity drug Qnexa

Smokers with higher math ability more likely to intend to quit

MU, MIT researchers evaluate accuracy of new technology to monitor blood glucose levels

Sandia receives four R&D Magazine's 2011 awards

NW Bio receives MHRA approval to initiate DCVax-L Phase III GBM brain cancer trial in the U.K.

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

VIVUS submits a NDA to the FDA for obesity drug Qnexa

Smokers with higher math ability more likely to intend to quit

MU, MIT researchers evaluate accuracy of new technology to monitor blood glucose levels

Sandia receives four R&D Magazine's 2011 awards

NW Bio receives MHRA approval to initiate DCVax-L Phase III GBM brain cancer trial in the U.K.

Urology Doctors in Portland, ME